NF-κB in carcinoma therapy and prevention

Author： Brown Matthew   Cohen Jonah   Arun Pattatheyil   Chen Zhong   Waes Carter Van  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.12, Iss.9, 2008-09, pp. : 1109-1122

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The NF-κB activation pathways, emerging molecular targets for cancer prevention and therapy

By Lin Yong   Bai Lang   Chen Wenjie   Xu Shanling  

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 1, 2010-01 ,pp. : 45-55

Informa Healthcare

Access to resources Recommend Favorite

NF-&kgr;B Signaling and Carcinogenesis

By  

Current Pharmaceutical Design, Vol. 13, Iss. 5, 2007-02 ,pp. : 447-462

Bentham Science Publishers

Access to resources Recommend Favorite

NF-κB – a target in the inflammation of bone destruction

By Doggrell Sheila A  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 1, 2005-02 ,pp. : 191-193

Informa Healthcare

Access to resources Recommend Favorite

Targeting NF-κB for colorectal cancer

By Sakamoto Kei   Maeda Shin  

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 6, 2010-06 ,pp. : 593-601

Informa Healthcare

Access to resources Recommend Favorite

Cloricromene in endotoxemia: role of NF-κB

By Ianaro A.   Maffia P.   Grassia G.   Meglio P.   Sorrentino R.   Villa Bianca R.   Rosa M.   Ialenti A.  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 370, Iss. 2, 2004-08 ,pp. : 140-145

Springer Publishing Company

Access to resources Recommend Favorite